10-QPeriod: Q2 FY2001

INTUITIVE SURGICAL INC Quarterly Report for Q2 Ended Jun 30, 2001

Filed August 10, 2001For Securities:ISRG

Summary

Intuitive Surgical, Inc. (ISRG) reported its second quarter and first half results for the period ending June 30, 2001. The company experienced significant year-over-year revenue growth, driven by an increase in the number of da Vinci Surgical Systems sold. Sales for the second quarter of 2001 were $12.7 million, a 148% increase compared to $5.1 million in the prior year's second quarter, and first-half sales reached $24.8 million, up 208% from $8.1 million in the same period last year. Despite strong revenue growth, the company continued to operate at a loss. The net loss for the second quarter was $4.2 million, a slight improvement from $4.5 million in the prior year's second quarter. The first-half net loss was $7.7 million, compared to $9.5 million in the first half of 2000. The company's gross profit margin improved substantially to 48% for the quarter and 47% for the first half, up from 32% and 25% respectively, due to sales growth and manufacturing efficiencies. Management believes current cash and short-term investments are sufficient to fund operations through at least 2002, but acknowledges potential future needs for additional financing.

Key Highlights

  • 1Total sales for the three months ended June 30, 2001, reached $12.7 million, a 148% increase compared to $5.1 million in the same period of 2000.
  • 2Total sales for the six months ended June 30, 2001, reached $24.8 million, a 208% increase compared to $8.1 million in the same period of 2000.
  • 3Gross profit margin improved significantly, from 32% in Q2 2000 to 48% in Q2 2001, and from 25% in H1 2000 to 47% in H1 2001, indicating improved manufacturing efficiencies and sales leverage.
  • 4The company reported a net loss of $4.2 million for the three months ended June 30, 2001, a slight decrease from $4.5 million in the prior year's quarter. The six-month net loss was $7.7 million, also an improvement from $9.5 million in the prior year.
  • 5Research and development expenses increased by 18% year-over-year for the quarter and 20% for the first half, reflecting continued investment in product development and enhancements.
  • 6Selling, general, and administrative expenses nearly doubled year-over-year for both the quarter (up 93%) and the first half (up 104%), driven by headcount additions to support revenue growth and the installed base.
  • 7As of June 30, 2001, the company held $74.5 million in cash and short-term investments, with management expressing confidence in sustaining operations through at least 2002.
  • 8The company is involved in significant patent litigation with Computer Motion, Inc. and Brookhill-Wilk 1, LLC, which presents potential risks regarding competitive position, costs, and the ability to sell products.

Frequently Asked Questions

Intuitive Surgical reported strong revenue growth. For the three months ended June 30, 2001, sales were $12.7 million, a 148% increase compared to $5.1 million in the same period of 2000. For the six months ended June 30, 2001, sales were $24.8 million, a 208% increase compared to $8.1 million in the prior year. This growth was primarily attributed to an increase in the number of da Vinci Surgical Systems sold.

No, Intuitive Surgical is not yet profitable and continues to report net losses. The net loss for the three months ended June 30, 2001, was $4.2 million, a slight improvement from $4.5 million in the prior year. The net loss for the six months ended June 30, 2001, was $7.7 million, also an improvement from $9.5 million in the first half of 2000. The company has a substantial accumulated deficit of $101.3 million as of June 30, 2001.

The company's gross profit margin has shown significant improvement. For the three months ended June 30, 2001, the gross profit margin was 48% of sales, up from 32% in the prior year. For the six-month period, the margin increased from 25% to 47%. This improvement is attributed to sales growth and increased manufacturing efficiencies.

Intuitive Surgical faces several significant risks and legal challenges. These include substantial operating losses and an accumulated deficit, long and variable sales cycles, reliance on a small number of key customers, the need for market acceptance of its new surgical technology, and a lengthy and uncertain regulatory process in the U.S. and internationally. Additionally, the company is involved in ongoing patent litigation with competitors like Computer Motion, Inc., which poses risks of significant costs, potential injunctions, and damage awards.